tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

ACXP Stock Latest News

Acurx files to sell 750,000 shares of common stock for holders
The FlyAcurx files to sell 750,000 shares of common stock for holders
11d ago
ACXP
Acurx awarded patent covering DNA Polymerase IIIC inhibitors by USPTO
PremiumThe Fly
Acurx awarded patent covering DNA Polymerase IIIC inhibitors by USPTO
11d ago
ACXP
One new option listing and option delistings on January 20th
PremiumThe Fly
One new option listing and option delistings on January 20th
24d ago
CVM
TEF
Acurx Pharmaceuticals: Promising Developments and Strategic Advances in Antibiotic Innovation
PremiumRatings
Acurx Pharmaceuticals: Promising Developments and Strategic Advances in Antibiotic Innovation
3M ago
ACXP
Acurx Pharmaceuticals Reports Q3 2025 Financial Results
PremiumCompany Announcements
Acurx Pharmaceuticals Reports Q3 2025 Financial Results
3M ago
ACXP
Acurx Pharmaceuticals’ Earnings Call: Achievements Amid Challenges
PremiumCompany AnnouncementsAcurx Pharmaceuticals’ Earnings Call: Achievements Amid Challenges
3M ago
ACXP
Optimistic Buy Rating for Acurx Pharmaceuticals Driven by Promising Developments and Financial Strength
Premium
Ratings
Optimistic Buy Rating for Acurx Pharmaceuticals Driven by Promising Developments and Financial Strength
3M ago
ACXP
Acurx reports Q3 EPS ($1.23) vs. ($3.45) last year
Premium
The Fly
Acurx reports Q3 EPS ($1.23) vs. ($3.45) last year
3M ago
ACXP
Acurx announces publication of results from ibezapolstat study
PremiumThe Fly
Acurx announces publication of results from ibezapolstat study
3M ago
ACXP
Is ACXP a Buy, Before Earnings?
PremiumPre-Earnings
Is ACXP a Buy, Before Earnings?
3M ago
ACXP
Acurx Pharmaceuticals’ Ibezapolstat: Promising Preclinical and Clinical Efficacy Supports Buy Rating
PremiumRatings
Acurx Pharmaceuticals’ Ibezapolstat: Promising Preclinical and Clinical Efficacy Supports Buy Rating
4M ago
ACXP
Acurx files to sell 585,000 shares of common stock for holders
PremiumThe Fly
Acurx files to sell 585,000 shares of common stock for holders
4M ago
ACXP
Acurx granted new patent for DNA Polymerase IIIC Inhibitors
PremiumThe FlyAcurx granted new patent for DNA Polymerase IIIC Inhibitors
4M ago
ACXP
Why Are Pharmaceutical Stocks XBIO, UPC, XTLB, & ACXP Up Today?
Premium
Market News
Why Are Pharmaceutical Stocks XBIO, UPC, XTLB, & ACXP Up Today?
4M ago
UPC
ACXP
Promising Outlook for Acurx Pharmaceuticals: Buy Rating Driven by Regulatory Milestones and Clinical Success of Ibezapolstat
Premium
Ratings
Promising Outlook for Acurx Pharmaceuticals: Buy Rating Driven by Regulatory Milestones and Clinical Success of Ibezapolstat
5M ago
ACXP
Acurx’s ibezapolstat receives positive EMA opinion in C. difficile infection
PremiumThe Fly
Acurx’s ibezapolstat receives positive EMA opinion in C. difficile infection
5M ago
ACXP
Acurx Pharmaceuticals Increases Authorized Common Stock Shares
PremiumCompany Announcements
Acurx Pharmaceuticals Increases Authorized Common Stock Shares
5M ago
8K
ACXP
Acurx Pharmaceuticals Shareholders Approve Key Issuance Plans
PremiumCompany Announcements
Acurx Pharmaceuticals Shareholders Approve Key Issuance Plans
5M ago
8K
ACXP
Acurx Pharmaceuticals’ Earnings Call: Optimism Amid Challenges
PremiumCompany Announcements
Acurx Pharmaceuticals’ Earnings Call: Optimism Amid Challenges
6M ago
ACXP
Acurx Pharmaceuticals Reports Reduced Losses Amid Ongoing R&D Efforts
PremiumCompany AnnouncementsAcurx Pharmaceuticals Reports Reduced Losses Amid Ongoing R&D Efforts
6M ago
ACXP
Acurx target adjusted to $31 from $8 at H.C. Wainwright
Premium
The Fly
Acurx target adjusted to $31 from $8 at H.C. Wainwright
6M ago
ACXP
Acurx reports Q2 EPS ($1.89) vs. ($5.21) last year
Premium
The Fly
Acurx reports Q2 EPS ($1.89) vs. ($5.21) last year
6M ago
ACXP

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >